source
- Treeline Biosciences to go public via reverse merger with Standard BioTools, securing runway to 2029Treeline Biosciences announced that it will become a publicly traded company through a reverse merger with Standard BioTools. The transaction is expected to list the combined entity on a U.S. excha…
- J&J to acquire Firefly Bio for $1 billion, boosting its KRAS-focused antibody-degrader programJohnson & Johnson announced it will purchase Firefly Bio, a preclinical biotech, for $1 billion in cash. Firefly Bio is developing degrader antibody conjugates that aim to target KRAS-driven cance…